Of those with pre-existing conditions, cancer patients are among those most vulnerable to SARS-CoV-2. It has been long known that this risk population also tends to have a higher incidence of deficiencies in micronutrients in general and selenium in particular. An insufficient nutritional status, in turn, worsens their prognosis. Indeed, a strong immune system helps fight infection and can destroy tumor cells. As a manufacturer of ethical pharmaceuticals, biosyn takes very seriously its commitment to improving everyone’s understanding of the immunological impact of the micronutrients it produces.
Citing current evidence, biosyn has just released two relevant new folders, Selenium deficiency and coronaviruses on the increased risk for cancer patients amid the COVID-19 pandemic and SARS-CoV-2-Increased risk for cancer patients describing the interrelationships between the micronutrient selenium, immunity and the pathogenicity and virulence of pathogens like the novel coronavirus. Neither is there any doubt about the imperative role diet plays in immunity. How important nutrients are to immune function is explained in a recent peer-reviewed article titled “Diet and Immune Function”. The open-access piece is available via PubMed and directly on the website of MDPI , the “Multidisciplinary Digital Publishing Institute”, a group committed to ethical publishing. To find out more about how selenium deficiency can be effectively remedied by selenase® pharmaceuticals, explore the biosyn website further.